Lifecore Biomedical, Inc. (LFCR) Financials
LFCR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Feb. 28, 2026 | 225.5 million | 204.7 million |
| Nov. 30, 2025 | 232.2 million | 198.1 million |
| Aug. 31, 2025 | 235.2 million | 198.4 million |
| May 31, 2025 | 239.3 million | 238.0 million |
LFCR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Feb. 28, 2026 | 3.6 million | 1.7 million |
| Nov. 30, 2025 | 3.6 million | ? |
| Aug. 31, 2025 | 25000 | 2.4 million |
| May 31, 2025 | 3.3 million | 1.8 million |
LFCR Net Income
No data available :(
LFCR Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Feb. 28, 2026 | 20.8 million | 142.1 million | 6.7 million |
| Nov. 30, 2025 | 17.5 million | 135.6 million | 6.8 million |
| Aug. 31, 2025 | 18.9 million | 129.3 million | 7.5 million |
| May 31, 2025 | 8.3 million | 127.0 million | 387000 |
LFCR Shares Outstanding
LFCR Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Feb. 28, 2026 | 1.1 million | 1.2 million | 7.9 million | - |
| Nov. 30, 2025 | 2.0 million | 2.3 million | 7.5 million | - |
| Aug. 31, 2025 | 1.7 million | 2.0 million | 8.9 million | - |
| May 31, 2025 | 2.1 million | 2.1 million | 9.0 million | - |
LFCR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Feb. 28, 2026 | 23.2 million | 18.7 million |
| Nov. 30, 2025 | 44.4 million | 28.5 million |
| Aug. 31, 2025 | 31.1 million | 23.3 million |
| May 31, 2025 | 36.4 million | 22.5 million |
LFCR
Price: $4.66
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.27 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 189.4 million